Within each cohort, subjects were randomised to once-daily treatment for 10 weeks with either oral semaglutide tablets (co-formulated with 300 mg SNAC), placebo tablets or placebo tablets with SNAC (300 mg)
Potential side effects Semaglutide generally has mild side effects such as nausea, diarrhea, vomiting, constipation, excessive burping, abdominal discomfort, stomach ache, and gastrointestinal problems
It is also important to watch for symptoms of low blood sugar
Do they have the same half-life
As a precautionary measure, the medication is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2